Valeo Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,456
| Closed | -$75K | – | 1594 |
|
|
2021
Q1 | $75K | Sell |
6,456
-1,400
| -18% | -$16.3K | ﹤0.01% | 685 |
|
|
2020
Q4 | $76K | Buy |
7,856
+4,350
| +124% | +$42.1K | ﹤0.01% | 629 |
|
|
2020
Q3 | $32K | Hold |
3,506
| – | – | ﹤0.01% | 768 |
|
|
2020
Q2 | $43K | Hold |
3,506
| – | – | ﹤0.01% | 753 |
|
|
2020
Q1 | $36K | Buy |
3,506
+800
| +30% | +$8.21K | ﹤0.01% | 684 |
|
|
2019
Q4 | $27K | Sell |
2,706
-165
| -6% | -$1.65K | ﹤0.01% | 839 |
|
|
2019
Q3 | $20K | Buy |
2,871
+1,400
| +95% | +$9.75K | ﹤0.01% | 841 |
|
|
2019
Q2 | $14K | Buy |
1,471
+264
| +22% | +$2.51K | ﹤0.01% | 935 |
|
|
2019
Q1 | $19K | Hold |
1,207
| – | – | ﹤0.01% | 803 |
|
|
2018
Q4 | $19K | Sell |
1,207
-330
| -21% | -$5.2K | ﹤0.01% | 718 |
|
|
2018
Q3 | $31K | Buy |
1,537
+224
| +17% | +$4.52K | ﹤0.01% | 646 |
|
|
2018
Q2 | $29K | Buy |
1,313
+550
| +72% | +$12.1K | ﹤0.01% | 663 |
|
|
2018
Q1 | $13K | Sell |
763
-1,914
| -71% | -$32.6K | ﹤0.01% | 860 |
|
|
2017
Q4 | $51K | Sell |
2,677
-771
| -22% | -$14.7K | 0.01% | 465 |
|
|
2017
Q3 | $61K | Buy |
+3,448
| New | +$61K | 0.01% | 375 |
|